| Winter's basic clinical pharmacokinetics P Beringer Lippincott Williams & Wilkins, 2023 | 603 | 2023 |
| Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy A Wong-Beringer, J Joo, E Tse, P Beringer International journal of antimicrobial agents 37 (2), 95-101, 2011 | 217 | 2011 |
| Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials A Aminimanizani, P Beringer, R Jelliffe Clinical pharmacokinetics 40, 169-187, 2001 | 186 | 2001 |
| The clinical use of colistin in patients with cystic fibrosis P Beringer Current opinion in pulmonary medicine 7 (6), 434-440, 2001 | 183 | 2001 |
| Textbook of therapeutics: drug and disease management RA Helms, DJ Quan Lippincott Williams & Wilkins, 2006 | 167 | 2006 |
| Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients E Minejima, J Choi, P Beringer, M Lou, E Tse, A Wong-Beringer Antimicrobial agents and chemotherapy 55 (7), 3278-3283, 2011 | 127 | 2011 |
| Economic aspects of antibacterial adverse effects PM Beringer, A Wong-Beringer, JP Rho Pharmacoeconomics 13, 35-49, 1998 | 95 | 1998 |
| Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis MJ Montgomery, PM Beringer, A Aminimanizani, SG Louie, BJ Shapiro, ... Antimicrobial agents and chemotherapy 45 (12), 3468-3473, 2001 | 78 | 2001 |
| Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administration PM Beringer, A Vinks, RW Jelliffe, BJ Shapiro Antimicrobial agents and chemotherapy 44 (4), 809-813, 2000 | 77 | 2000 |
| Transporters and their impact on drug disposition PM Beringer, RL Slaughter Annals of Pharmacotherapy 39 (6), 1097-1108, 2005 | 76 | 2005 |
| Remington: the science and practice of pharmacy P Beringer, JP Remington Lippincott Williams & Wilkins, 2006 | 75 | 2006 |
| Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features PM Beringer, MD Appleman Current opinion in pulmonary medicine 6 (6), 545-550, 2000 | 68 | 2000 |
| Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis P Beringer, KMT Huynh, J Kriengkauykiat, L Bi, N Hoem, S Louie, E Han, ... Antimicrobial agents and chemotherapy 49 (12), 5013-5017, 2005 | 63 | 2005 |
| Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings P Beringer, M Nguyen, N Hoem, S Louie, M Gill, M Gurevitch, ... Antimicrobial agents and chemotherapy 49 (9), 3676-3681, 2005 | 57 | 2005 |
| Pharmacokinetics of doxycycline in adults with cystic fibrosis PM Beringer, H Owens, A Nguyen, D Benitez, A Rao, DZ D'Argenio Antimicrobial agents and chemotherapy 56 (1), 70-74, 2012 | 56 | 2012 |
| Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis A Aminimanizani, PM Beringer, J Kang, L Tsang, RW Jelliffe, BJ Shapiro Journal of Antimicrobial Chemotherapy 50 (4), 553-559, 2002 | 55 | 2002 |
| Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease T Nguyen, SG Louie, PM Beringer, MA Gill Current opinion in pulmonary medicine 8 (6), 521-528, 2002 | 52 | 2002 |
| GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis PM Beringer, L Hidayat, A Heed, L Zheng, H Owens, D Benitez, AP Rao Journal of Cystic Fibrosis 8 (1), 19-25, 2009 | 51 | 2009 |
| A comparison of phenytoin‐loading techniques in the emergency department SP Swadron, MI Rudis, K Azimian, P Beringer, D Fort, M Orlinsky Academic emergency medicine 11 (3), 244-252, 2004 | 46 | 2004 |
| Stability and antibacterial activity of cefepime during continuous infusion PF Sprauten, PM Beringer, SG Louie, TW Synold, MA Gill Antimicrobial agents and chemotherapy 47 (6), 1991-1994, 2003 | 46 | 2003 |
